Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Osteosarcoma subtypes based on platelet-related genes and tumor microenvironment characteristics. | Front Oncol | 2022 | 36212395 | PubTator, text mining | PubMed |
| The Innate and Adaptive Immune Cells in Alzheimer's and Parkinson's Diseases. | Oxid Med Cell Longev | 2022 | 36211819 | PubTator, text mining | PubMed |
| Ex vivo exposures to arsenite and its methylated trivalent metabolites alter gene transcription in mouse sperm cells. | Toxicol Appl Pharmacol | 2022 | 36209798 | PubTator, text mining | PubMed |
| Identification of core genes and pathways between geriatric multimorbidity and renal insufficiency: potential therapeutic agents discovered using bioinformatics analysis. | BMC Med Genomics | 2022 | 36209090 | PubTator, text mining | PubMed |
| AXL, along with PROS1, is overexpressed in papillary thyroid carcinoma and regulates its biological behaviour. | World J Surg Oncol | 2022 | 36203174 | PubTator, text mining | PubMed |
| Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease. | Chem Res Toxicol | 2022 | 36197742 | PubTator, text mining | PubMed |
| Identification and validation of key molecules associated with humoral immune modulation in Parkinson's disease based on bioinformatics. | Front Immunol | 2022 | 36189230 | PubTator, text mining | PubMed |
| Developments and challenges of FLT3 inhibitors in acute myeloid leukemia. | Front Oncol | 2022 | 36185253 | PubTator, text mining | PubMed |
| Urinary proteome analysis of acute kidney injury in post-cardiac surgery patients using enrichment materials with high-resolution mass spectrometry. | Front Bioeng Biotechnol | 2022 | 36177176 | PubTator, text mining | PubMed |
| Potential gene identification and pathway crosstalk analysis of age-related macular degeneration. | Front Genet | 2022 | 36147504 | PubTator, text mining | PubMed |
| African Swine Fever Vaccinology: The Biological Challenges from Immunological Perspectives. | Viruses | 2022 | 36146827 | PubTator, text mining | PubMed |
| The Roles of Skin Langerhans Cells in Immune Tolerance and Cancer Immunity. | Vaccines (Basel) | 2022 | 36146458 | PubTator, text mining | PubMed |
| Exome-Wide Association Study Reveals Host Genetic Variants Likely Associated with the Severity of COVID-19 in Patients of European Ancestry. | Life (Basel) | 2022 | 36143338 | PubTator, text mining | PubMed |
| Identification of Key Genes and Pathways in Genotoxic Stress Induced Endothelial Dysfunction: Results of Whole Transcriptome Sequencing. | Biomedicines | 2022 | 36140167 | PubTator, text mining | PubMed |
| Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines. | Cancers (Basel) | 2022 | 36139627 | PubTator, text mining | PubMed |
| Bone Marrow Endothelial Cells Increase Prostate Cancer Cell Apoptosis in 3D Triculture Model of Reactive Stroma. | Biology (Basel) | 2022 | 36138750 | PubTator, text mining | PubMed |
| Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma. | Cell Rep Med | 2022 | 36130479 | PubTator, text mining | PubMed |
| Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast. | Nat Commun | 2022 | 36127427 | PubTator, text mining | PubMed |
| Molecular mechanisms of resistance to tyrosine kinase inhibitor in clear cell renal cell carcinoma. | Int J Urol | 2022 | 36122306 | PubTator, text mining | PubMed |
| Spatiotemporal control of actomyosin contractility by MRCKβ signaling drives phagocytosis. | J Cell Biol | 2022 | 36121394 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=41